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Abstract 
Exogenous IgE acts as an adjuvant in tumor vaccination in mice, and therefore a direct role of 
endogenous IgE in tumor immunosurveillance was investigated. By using genetically engineered 
mice, we found that IgE ablation rendered mice more susceptible to the growth of transplantable 
tumors. Conversely, a strengthened IgE response provided mice with partial or complete resistance 
to tumor growth, depending on the tumor type. By genetic crosses, we showed that IgE-mediated 
tumor protection was mostly lost in mice lacking FceRI. Tumor protection was also lost after 
depletion of CD8+ T cells, highlighting a cross-Talk between IgE and T cell- mediated tumor 
immunosurveillance. Our findings provide the rationale for clinical observations that relate atopy 
with a lower risk for developing cancer and open new avenues for the design of immunotherapeutics 
relevant for clinical oncology. The Journal of Immunology, 2016, 197: 2583-2588. 
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